Technology

#Innovation #IXICO #Neuroscience #Precision medicine #Technology

The resurgence of neuroscience

Bram Goorden, CEO, IXICO, looks at why precision medicine is the next frontier for neuroscience. For much of the early 2000s, neuroscience was one of the pharmaceutical industry’s most challenging therapeutic areas. Clinical failures accumulated and investors increasingly favoured oncology, where biomarker-driven drug development… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology

This week in Drug Discovery (26-30 October)

News round-up for 26-30 October 2026 by Megan Thomas, Multimedia Editor at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Conference in London, as well as four stories that showcase the far reaching impact of artificial intelligence (AI) in drug discovery. The… Read More

#News

#Biotechnology #Cancer research #Clinical trials #Drug development #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (19-23 October)

News round-up for 19-23 October 2026 by Megan Thomas, Multimedia Editor at DDW.  In this week’s news roundup, drug discovery and biopharma companies continue to make progress across the drug development pipeline, with recent updates highlighting clinical trial milestones, emerging research and investment in new treatments. The… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Rare disease #Technology #Tumours

This week in Drug Discovery (12-16 October)

News round-up for 12-16 October 2026 by Megan Thomas, Multimedia Editor at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Conference in London, as well as new initiatives to accelerate rare disease drug development, promising preclinical data for Duchenne muscular dystrophy, clinical trial… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (5-9 October 2026) 

News round-up for 5-9 October, 2026 by Megan Thomas, Multimedia Editor at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Conference in London, as well as some promising updates in cancer research and immunotherapy, particularly the development of new treatments and how… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (28 September – 2 October 2026) 

News round-up for 28 September – 2 October 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers the upcoming the Drug Discovery Innovators & Investors Conference in London, as well as global updates on cancer research. The top stories:  In-person… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (21-25 September 2026) 

News round-up for 21-25 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Digital Forum and the Drug Discovery Innovators & Investors Conference in London, as well as the latest developments in drug discovery,… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (14-18 September 2026) 

News round-up for 14-18 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Digital Forum and the Drug Discovery Innovators & Investors Conference in London, changes to US scientific research grant screening, the UK’s… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (7-11 September 2026) 

News round-up for 7-11 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers upcoming Drug Discovery Innovators & Investors (DDII) in-person events and forum updates, alongside the latest Phase II clinical data across coeliac disease, bronchiectasis and head and neck cancer. Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (31 August – 4 September 2026) 

News round-up for 31 August – 4 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers new developments in vaccines, drug approvals, cardiovascular therapies and cancer drug response, alongside DDW’s upcoming digital forum focused on the technologies, strategies and investment trends shaping… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (17-21 August 2026) 

News round-up for 17-21 August by Megan Thomas, Content Team at DDW.  This week’s news roundup covers new therapeutic approaches moving towards or through clinical development, alongside advances in drug discovery and the investment landscape supporting biotech innovation. The top stories:  DDII Digital Forum:… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (27-31 July 2026) 

News round-up for 27-31 July by Megan Thomas, Content Team at DDW.  This week’s news roundup centres around investment, innovation and strategic growth, which have dominated this week’s headlines. Across the drug discovery sector, companies have secured funding, expanded R&D capabilities and accelerated the adoption of AI-driven… Read More

#News

2024 predictions, road forward
#2024 predictions #AI / data analytics / healthtech / informatics #Antiverse #Artificial intelligence (AI) #Drug discovery #Elsevier #Enhanc3D Genomics #IQVIA #Lab automation #Machine learning #Medidata #Ori Biotech #Technology #TrakCel #Trinity Life Sciences

2024 predictions: Experts comment on AI, ML and automation

DDW’s Megan Thomas spoke to experts from the drug discovery industry about their predictions on what 2024 holds for our sector. This is part of a series of predictions based on different themes. Here, experts weigh in on the impact of artificial intelligence (AI), machine learning (ML) and automation in… Read More

#Exclusive Content #Opinion #Trends & Analysis

Cancer Research
#Cancer research #Cancer Research Horizons #Precision medicine #Regulatory #Start-ups #Technology

Conversations from Cancer Research Horizons’ Innovation Summit 2023 

Cancer Research Horizon’s Innovation Summit 2023 took place on 21 November 2023 at the Royal Society of Medicine, and included talks from researchers translating their research, as well as networking with members of the entrepreneurial ecosystem. DDW’s Megan Thomas spoke to a range of attendees.   Trends… Read More

#Cancer Research #Exclusive Content #Opinion #Regulatory

#AI / data analytics / healthtech / informatics #Biotechnology #Drug development #Drug discovery #Technology

This week in drug discovery (11-15 September)  

News round-up for 11-15 September by DDW Digital Content Editor Diana Spencer. Spanning artificial intelligence, theranostics, radiopharmaceuticals, quantum simulation and small regulatory RNA, the top stories this week all cover cutting-edge technologies and techniques making a huge impact on modern drug discovery and development. Read More

#News

Workcell with a microfluidic chip testing thousands of AI-designed proteins
#Adaptyv Bio #AI #Automation / robotics #Enzymes #Generative AI #Life sciences #Protein engineering #Technology

A new paradigm for protein engineering 

Adaptyv Bio, a Swiss/US technology company that develops infrastructure and tools for protein designers to engineer better proteins, has built a protein engineering foundry that it says will “pave the way” for protein designers to develop new medicines, novel enzymes and sustainable materials. AI tools like ChatGPT… Read More

#News